Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Babir Basir: Next Steps in Light of DanGer Shock Results

Mir Babar Basir, D.O., discusses what he sees as the next steps in managing cardiogenic shock in light of the DanGer Shock RCT results.

Amir Kaki: Minimizing Bleeding and Vascular Complications Seen in DanGer Shock and Optimizing Outcomes

Amir Kaki, M.D., discusses complications reported in the DanGer Shock RCT and best practices for improving complication rates and optimizing outcomes.

Katherine Kunkel: Troubleshooting with an Eye on the Prize

Katherine Kunkel, MD, discusses how to leverage the science from DanGer Shock and further reduce adverse events and improve outcomes.

Babar Basir, DO: CERAMICS Trial  

Babar Basir, DO, discusses CERAMICS, a trial designed to be a next step to NCSI.

Thursday Night Live: Highway to the DanGer Zone

Mitul Patel, M.D., Alexander Truesdell, M.D. and Katherine Kunkel, M.D., discuss the implications of the DanGer Shock RCT for community and academic centers.

DanGer Shock Discussion with Jacob Møller at TCT 2024

Jacob Møller, M.D., and Chuck Simonton, M.D., discuss the DanGer Shock RCT and new data presented at TCT 2024.

Ripped From the Headlines of ACC: DanGer Shock RCT Results

A panel of interventional cardiologists discuss the DanGer Shock RCT results and the implications for AMICS patient management.

Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients - A Glimpse into the Future

This article examines current evidence for the use of mechanical circulatory support (MCS) in cardiogenic shock and discusses how the scientific community can advance research in this area.

Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients

Experts throughout Europe have contributed to this European Heart Journal supplement with articles discussing best practices for successfully managing mechanical circulatory support (MCS) in patients with cardiogenic shock.

Recognizing Patients as Candidates for Mechanical Circulatory Support Along the Spectrum of Cardiogenic Shock

This paper discusses the latest guidance for identifying patients with cardiogenic shock (CS) who are candidates for mechanical circulatory support (MCS).

Renal Protection and Hemodynamic Improvement by Impella® Heart Pumps

Birgit Markus, MD, discusses data on the impact of Impella® heart pump support on hemodynamics and renal function in patients with cardiogenic shock.

 The Current State of MCS for AMICS  

William O’Neill, MD, discusses the current state of mechanical circulatory support for AMI cardiogenic shock.
 

Optimizing AMICS Patient Care Prior to Leaving the Cath Lab

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

Using Administrative/Payer Databases: Limitations and Utility

Chuck Simonton, MD, discusses the limitations of published papers that use administrative or payer databases as data sources and provides an AMI cardiogenic shock example.

HFSA 2021: Managing AMI Cardiogenic Shock Using the National Cardiogenic Shock Initiative Study Protocol

Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].